LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.00 | 771.67 | 1344 | 3884 | 0.3460 | 0.2687 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.00 | 771.67 | 1536 | 3884 | 0.3954 | 0.3434 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.22 | 771.67 | 1320 | 4299 | 0.3070 | 0.2419 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.22 | 771.67 | 1564 | 4299 | 0.3638 | 0.3299 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 40.44 | 771.67 | 1361 | 4738 | 0.2872 | 0.2420 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 40.44 | 771.67 | 1585 | 4738 | 0.3345 | 0.3164 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 42.67 | 771.67 | 1353 | 5155 | 0.2624 | 0.2274 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 42.67 | 771.67 | 1572 | 5155 | 0.3049 | 0.2965 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 44.89 | 771.67 | 1360 | 5541 | 0.2454 | 0.2205 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 44.89 | 771.67 | 1597 | 5541 | 0.2882 | 0.2914 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.11 | 771.67 | 1388 | 5941 | 0.2336 | 0.2206 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.11 | 771.67 | 1671 | 5941 | 0.2812 | 0.3000 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.33 | 771.67 | 1403 | 6392 | 0.2195 | 0.2165 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.33 | 771.67 | 1719 | 6392 | 0.2689 | 0.3003 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 51.55 | 771.67 | 1431 | 6829 | 0.2095 | 0.2169 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 51.55 | 771.67 | 1727 | 6829 | 0.2529 | 0.2919 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.77 | 771.67 | 1496 | 7256 | 0.2062 | 0.2272 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.77 | 771.67 | 1762 | 7256 | 0.2428 | 0.2909 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.99 | 771.67 | 1538 | 7690 | 0.2000 | 0.2311 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.99 | 771.67 | 1789 | 7690 | 0.2326 | 0.2885 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 58.21 | 771.67 | 1551 | 8085 | 0.1918 | 0.2287 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 58.21 | 771.67 | 1838 | 8085 | 0.2273 | 0.2918 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 60.44 | 771.67 | 1579 | 8530 | 0.1851 | 0.2294 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 60.44 | 771.67 | 1904 | 8530 | 0.2232 | 0.2976 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.66 | 771.67 | 1595 | 8978 | 0.1777 | 0.2276 | MN20160304_L01 | D07 |